Irifour News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Irifour. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Irifour Today - Breaking & Trending Today

Cantargia AB: Cantargia advances TRIFOUR trial to randomized stage following promising early safety and efficacy of nadunolimab in triple-negative breast cancer

LUND, Sweden, Feb. 23, 2023 /PRNewswire/ Cantargia (Cantargia AB) (NASDAQ Stockholm: CANTA) today reported favorable safety and promising early signs of efficacy following an initial analysis ....

Dennis Riedl , Durani Reynals , Agostina Stradella , Prnewswire Cantargia , Catalan Institute Of Oncology , Spanish Breast Cancer Group , Principal Investigator , Catalan Institute , Nasdaq Stockholm ,

Cantargia AB: Cantargia reports positive safety data from CIRIFOUR clinical study on nadunolimab and pembrolizumab combination

STOCKHOLM, Feb. 3, 2022 /PRNewswire/ Cantargia AB today reported an interim update on the first part of the phase Ib clinical study CIRIFOUR. Fifteen cancer patients no longer responding ....

Nasdaq Stockholm ,

Cantargia AB: Cantargia reports treatment of first triple negative breast cancer patient in TRIFOUR study

STOCKHOLM, Jan. 14, 2022 /PRNewswire/ Cantargia AB today reported treatment of the first triple negative breast cancer (TNBC) patient with nadunolimab and chemotherapy in the phase Ib/II ....

Spanish Breast Cancer Group , Nasdaq Stockholm ,

Cantargia expands CIRIFOUR trial after successful completion of recruitment in the pembrolizumab combination arm

STOCKHOLM, Aug. 19, 2021 /PRNewswire/ Cantargia AB today announced that the last patient in the initial treatment arm of the phase Ib clinical study CIRIFOUR has started treatment. A total ....

Nasdaq Stockholm , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் ,